ASHLEIGH RUTKA: Open Payments
NPI 1376940536 · RANDALLSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 11 payments from 7 companies in 2025. Trend: 2023 $594 · 2024 $444 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $58 |
| Kestra Medical Technology Services, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Janssen Biotech, Inc. | 1 | $28 |
| Chiesi USA, Inc. | 1 | $25 |
Products named: DALVANCE, Assure WCD, XIFAXAN, ULTOMIRIS, ZERBAXA, TECVAYLI, MYCAPSSA.
Industry payments across MD — which companies pay providers there.
